COVID-19 Healthcare Impact: Biosurveillance Atlas

Hear more about Ipsos’ BioSurveillance Atlas and how our healthcare clients are leveraging this capability for making real-time, expedient and data-driven decisions during this unprecedented time of uncertainty.

 

The pandemic involving COVID-19 continues to mature and making educated and real-time decisions in an evolving crisis requires access to and use of disparate information sources and applying advanced research methods to better understand the public's reaction to the crisis.

Applying these capabilities will help improve decisionmakers’ ability to understand the public’s perception and response to government policies which in turn allows localized management of the evolving crisis. With the priority of creating better health outcomes for our citizens, real-time knowledge of public perceptions and opinions can help inform decision-makers on how to strategically communicate with stakeholders and increase preparedness by understanding public sentiment and behaviors at either a national or local level view. 

View our on demand webinar with Ipsos Public Affairs President, Dr. Clifford Young, and global BioSurveillance expert, Mark Polyak, to hear more about Ipsos’ BioSurveillance Atlas and how our healthcare clients are leveraging this capability for making real-time, expedient and data-driven decisions during this unprecedented time of uncertainty.

For more information, please send inquiries to [email protected]
 

The author(s)

  • Clifford Young
    President, US, Public Affairs
  • Mark Polyak
    President of Analytics, Ipsos North America
  • Jan Hodes
    Senior Vice President, Health Services Research

Related news